Immunologic Memory (Supp. of ATN 024)
HIV Infections
About this trial
This is an interventional prevention trial for HIV Infections focused on measuring Hepatitis B vaccines, HIV-infected adolescents, Hepatitis B infection
Eligibility Criteria
Inclusion Criteria: Subjects that are eligible for participation in ATN 024 and ATN 025 are eligible for ATN 048. Subjects consented for ATN 024 or ATN 025 should be consented for ATN 048 at the same time. A written informed assent/consent must be obtained from the subject along with written parental/legal guardian permission as determined by the local IRB before any study-related procedures are performed.
Sites / Locations
- Childrens Hosp of Los Angeles
- University of California at San Francisco
- Children's Hosp Natinal Med Center
- Tulane Med Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Active Comparator
Experimental
Active Comparator
Experimental
Experimental
A1: ATN 024 Energix-B Standard Adult Dose
A2: ATN 024 Engerix-B Increased Adult Dose
A3: ATN 024 Twinrix Standard Adult Dose
B1: ATN 025 Recombivax
B2: ATN 025 Twinrix